Precision Nanomedicine

What can the metabolism of 606 people from China, the Netherlands and Australia tell us about the onset and progression of ALS? Turns out, quite a bit.

Ovarian cancer is notoriously difficult to pick up and claims the lives of 1000 women every year. AIBN researchers are hoping to change that with a new, portable blood test.

For three months Tahmina Tabassum relearned what she knew about industry and entrepreneurship during a placement with biotech Azafaros BV, a whirlwind experience that included a stint at the company’s headquarters in Basel.

Professor Kris Thurecht and the AIBN team are working to improve the targeting ability of these molecules to unlock the power of radiopharmaceuticals.

Early work has begun at the AIBN on a synthetic, drug-free solution that helps osteoarthritis patients with problem joints.

AIBN researchers want HIV patients to have the option of taking a long-acting antiretroviral dose once a week, instead of having to take a dose every day.

AIBN researchers are exploring potential nanoscale processes that explain how the body's text messages move about.

AIBN researchers are developing new 4D printing technology that produces shape-shifting liquid metals for soft robotics.